- India has granted the emergency use approval for the COVID-19 vaccine developed by AstraZeneca (NASDAQ:AZN) and the Oxford University, a day after an advisory panel in the country issued its recommendation.
- Announcing the decision, Information and Broadcasting Minister Prakash Javadekar told reporters on Saturday at least three more vaccines were on track to receive the approval: local company Bharat Biotch’s COVAXIN, Zydus Cadila’s ZyCoV-D, and Russia’s Sputnik-V.
- According to reports, the Indian regulator has also received an emergency-use application for the COVID-19 vaccine made by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX).
- The announcement of the approval comes on the day of a nationwide drill in India testing the vaccine delivery system as the country with the second-largest population and second-highest number of COVID-19 cases prepares to kick start the inoculation of 300M people under the first phase of the vaccination campaign.
- https://seekingalpha.com/news/3648182-astrazeneca-receives-emergency-use-nod-for-coronavirus-vaccine-in-india
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.